Bryan, Garnier & Co announces its annual IPO Conference "Going Public in 2014"
Paris, May 5th, 2014 - Bryan, Garnier & Co is delighted to announce its annual IPO Conference, which will be held in Paris on Tuesday, the 13th of May 2014, in partnership with EnterNext, Deloitte and ACTUS, and with the support of AFDEL and France Biotech.
In a buoyant IPO market which has not been experienced for half a decade, the opportunity of going public to raise growth capital or to access liquidity is being broadly evaluated by the management of growth companies and their shareholders.
The Conference is offering board members and senior executives of growth companies, private equity and venture capital professionals, a unique and timely opportunity to seize the current IPO market dynamics, and the key issues arising from the evaluation of an IPO track and its implementation to best take advantage of the current favourable IPO market.
Corporate management, VCs and Institutional Investors are invited to attend this event free of charge.
Due to limited seating capacity, we advise you to register quickly to confirm your presence.
For further information, please visit our website
About Bryan, Garnier & Co (www.bryangarnier.com)
Bryan, Garnier & Co is an international growth focused independent investment bank with operations in London, Paris, Geneva, New York and New Delhi. The firm employs 120 professionals and provides investment management, equity research, sales & trading and investment banking (private and public capital raising and M&A) services to growth companies and their investors, with a focus on the TMT, Healthcare, Renewable Energies & Environment, Specialty Retail and Business Services industry sectors. Bryan, Garnier & Co regularly keeps top spot in the European M&A and Equity Capital Markets league tables in Technology, Media Telecom and Healthcare sectors. The firm benefits from a strong recognition of its pan-European equity research activity which was awarded Most Productive European Broker for 2013 by Financial Times / Starmine. In April 2014, Bryan, Garnier & Co investment banking activities were awarded best investment bank of the year in TMT and Healthcare by Leaders League.
Recently, Bryan, Garnier & Co led the largest healthcare IPO on NYSE Euronext in H1 2013, was joint lead manager and bookrunner of LDR Nasdaq IPO in October 2013, acted as sole manager of Transgene 65m€ PIPE-, led one of the largest European private placement for Merieux Nutrisciences, and acted as lead manager of Erytech, Genomic Vision and McPhy Energy IPOs on NYSE Euronext.
Bryan, Garnier & Co is a fully registered broker dealer authorized by the FCA in Europe and by the FINRA in the USA, is a member of the London Stock Exchange, a member of NYSE Euronext and a listing sponsor on Alternext. In April 2014, the firm announced a strategic alliance with City stockbroker Westhouse Securities to increase its presence on the UK domestic small cap market segment